As of 2026-09-23, the Relative Valuation of Harpoon Therapeutics Inc (HARP) is (25.08) USD. This relative valuation is based on P/E multiples. With the latest stock price at 23.01 USD, the upside of Harpoon Therapeutics Inc based on Relative Valuation is -209.0%.
The range of the Relative Valuation is (13.91) - (29.93) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.8x - 22.3x | 19.3x |
| Forward P/E multiples | 9.4x - 21.0x | 15.9x |
| Fair Price | (13.91) - (29.93) | (25.08) |
| Upside | -160.5% - -230.1% | -209.0% |
| Date | P/E |